- Aug 12, 2011
- 6,710
- 730
- 155
The pharmaceutical industry defends the price spikes as a means of funding research to develop new drugs. But a close look at the finances of more than a dozen public drug companies illustrates research and development expenses are routinely smaller than company overheads, including marketing costs. And often after-tax profits still greatly exceed those R&D expenses that the companies say are so high.
Corporate America! What a joke.
The real reason U.S. drug prices are so high
Corporate America! What a joke.
The real reason U.S. drug prices are so high